IT201700091733A1 - Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo - Google Patents

Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo

Info

Publication number
IT201700091733A1
IT201700091733A1 IT102017000091733A IT201700091733A IT201700091733A1 IT 201700091733 A1 IT201700091733 A1 IT 201700091733A1 IT 102017000091733 A IT102017000091733 A IT 102017000091733A IT 201700091733 A IT201700091733 A IT 201700091733A IT 201700091733 A1 IT201700091733 A1 IT 201700091733A1
Authority
IT
Italy
Prior art keywords
disorders
therapeutic
composition
oral administration
reflux disease
Prior art date
Application number
IT102017000091733A
Other languages
English (en)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102017000091733A priority Critical patent/IT201700091733A1/it
Priority to PCT/IB2018/055854 priority patent/WO2019030629A1/en
Priority to EP18762148.7A priority patent/EP3664852A1/en
Publication of IT201700091733A1 publication Critical patent/IT201700091733A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IT102017000091733A 2017-08-08 2017-08-08 Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo IT201700091733A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102017000091733A IT201700091733A1 (it) 2017-08-08 2017-08-08 Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo
PCT/IB2018/055854 WO2019030629A1 (en) 2017-08-08 2018-08-03 COMPOSITION FOR ORAL ADMINISTRATION IN THERAPEUTIC OR PREVENTIVE TREATMENT OF DISORDERS OR DISEASE OF GASTROESOPHAGEAL REFLUX
EP18762148.7A EP3664852A1 (en) 2017-08-08 2018-08-03 A composition for oral administration in the therapeutic or preventive treatment of gastroesophageal reflux disorders or disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000091733A IT201700091733A1 (it) 2017-08-08 2017-08-08 Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo

Publications (1)

Publication Number Publication Date
IT201700091733A1 true IT201700091733A1 (it) 2019-02-08

Family

ID=60991127

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000091733A IT201700091733A1 (it) 2017-08-08 2017-08-08 Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo

Country Status (3)

Country Link
EP (1) EP3664852A1 (it)
IT (1) IT201700091733A1 (it)
WO (1) WO2019030629A1 (it)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050005A1 (en) * 1999-02-24 2000-08-31 Dong Wha Pharm. Ind. Co., Ltd Liquid suppository composition of diclofenac sodium
WO2007133082A1 (en) * 2006-05-16 2007-11-22 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
US20110229569A1 (en) * 2008-09-22 2011-09-22 Rubicon Research Private Limited Compositions exhibiting delayed transit through the gastrointestinal tract
PL218041B1 (pl) * 2006-06-28 2014-09-30 Akademia Medyczna Im Piastów Śląskich We Wrocławiu Zastosowanie Poloksameru 407 wraz z metylocelulozą do wytwarzania płynnego leku do osłony i leczenia błony śluzowej oraz sposób jego wytwarzania

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050005A1 (en) * 1999-02-24 2000-08-31 Dong Wha Pharm. Ind. Co., Ltd Liquid suppository composition of diclofenac sodium
WO2007133082A1 (en) * 2006-05-16 2007-11-22 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides
PL218041B1 (pl) * 2006-06-28 2014-09-30 Akademia Medyczna Im Piastów Śląskich We Wrocławiu Zastosowanie Poloksameru 407 wraz z metylocelulozą do wytwarzania płynnego leku do osłony i leczenia błony śluzowej oraz sposób jego wytwarzania
US20110229569A1 (en) * 2008-09-22 2011-09-22 Rubicon Research Private Limited Compositions exhibiting delayed transit through the gastrointestinal tract

Also Published As

Publication number Publication date
EP3664852A1 (en) 2020-06-17
WO2019030629A1 (en) 2019-02-14

Similar Documents

Publication Publication Date Title
CY1122566T1 (el) Παραγωγο 6,7,8,9-tetpaϋδpo-3h-πυραζολo[4,3-f] ισοκινολινης χρησιμο στη θεραπευτικη αντιμετωπιση του καρκινου
CY1120429T1 (el) Παραγωγα κιναζολινης για τη θεραπευτικη αντιμετωπιση ιογενων λοιμωξεων και αλλων νοσων
MX2020010484A (es) Derivados de heterociclilos sustituidos como inhibidores de cdk.
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
EP3686200A3 (en) Bicyclic heterocycle compounds and their uses in therapy
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
WO2016109217A3 (en) Btk inhibitors
IT201600121601A1 (it) Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
ECSP16008797A (es) Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos
PH12016502353A1 (en) Pharmaceutical composition
CL2015002346A1 (es) Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
TW201613577A (en) Pharmaceutical combinations
TR201821157T4 (tr) İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m.
IT201800001301A1 (it) Formulazioni in gel per la somministrazione orale di farmaci, in particolare nei pazienti disfagici
BR112019004684A2 (pt) combinação de agonistas de fxr
IT201700047189A1 (it) Composti e composizioni per il trattamento di cancro, disordini della retina e cardiomiopatie
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
IL277238A (en) Modified oligonucleotides for use in the treatment of tauopathy
LT3124048T (lt) Kompozicija skirta vartoti per burną gastroezofaginio refliukso ligos ar skausmo gydymui
SMT201600460B (it) Composizione farmaceutica per uso nel trattamento o prevenzione delle carenze di vitamine e minerali in pazienti che sono stati sottoposti a chirurgia di bypass gastrico
IL269400A (en) Medicines and preparations for the treatment of eye disorders
EA201691796A1 (ru) П-замещенные асимметричные мочевины и их применение в медицине
IL277041A (en) Modulators of small conductance calcium activated k channels and pharmaceutical compositions for use in the treatment of lesional vestibular disorders
WO2017075264A8 (en) Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders